Literature DB >> 12872839

Characteristic growth pattern in male X-linked phosphorylase-b kinase deficiency (GSD IX).

H M Schippers1, G P A Smit, J P Rake, G Visser.   

Abstract

Growth retardation is one of the clinical characteristics of glycogen storage disease (GSD) type IX. Initial growth retardation has been described in a few case reports, followed by a complete catch-up in growth. This study aimed to determine the growth pattern of patients with GSD IX. Growth charts of 51 male Dutch patients with GSD IX (age 0-33 years, median follow-up time 8.3 years (range 0-30.5 years)) were studied retrospectively and compared with Dutch standard growth charts. Patients had a normal height at birth, significant growth retardation between the ages of 2 and 10 years (mean z-score -1.96), delayed growth spurt in puberty and catch-up towards quite normal final height (mean z-score -0.55). We conclude that GSD IX patients have a specific growth pattern characterized by initial growth retardation, a late growth spurt and complete catch-up in final height. Intervention for growth retardation is therefore in general not warranted. It is speculated that mild hypoglycaemia related to the disorder may cause endocrine changes. Because the glucose need per kg bodyweight decreases with age, the enzyme defect becomes less important with ageing and the effect on growth diminishes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872839     DOI: 10.1023/a:1024071328772

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience.

Authors:  I Maire; C Baussan; N Moatti; M Mathieu; A Lemonnier
Journal:  Clin Biochem       Date:  1991-04       Impact factor: 3.281

Review 2.  Genetic deficiencies of the glycogen phosphorylase system.

Authors:  J Hendrickx; P J Willems
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

3.  The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients.

Authors:  P J Willems; W J Gerver; R Berger; J Fernandes
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

Review 4.  Fatal infantile hypertrophic cardiomyopathy secondary to deficiency of heart specific phosphorylase b kinase.

Authors:  M Elleder; Y S Shin; A Zuntová; P Vojtovic; V Chalupecký
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency.

Authors:  A Nakai; Y Shigematsu; T Takano; Y Kikawa; M Sudo
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

6.  Patterns of growth in the hepatic glycogenoses.

Authors:  D B Dunger; J V Leonard; M A Preece
Journal:  Arch Dis Child       Date:  1984-07       Impact factor: 3.791

7.  Growth in children with chronic renal failure on conservative treatment.

Authors:  G Rizzoni; T Basso; M Setari
Journal:  Kidney Int       Date:  1984-07       Impact factor: 10.612

Review 8.  Growth hormone therapy in short children without classical growth hormone deficiency.

Authors:  J R Bierich
Journal:  J Endocrinol Invest       Date:  1989       Impact factor: 4.256

Review 9.  Pain syndromes, disability, and chronic disease in childhood.

Authors:  P N Malleson
Journal:  Curr Opin Rheumatol       Date:  1991-10       Impact factor: 5.006

  9 in total
  10 in total

1.  Biochemical characteristics and increased tetraglucoside excretion in patients with phosphorylase kinase deficiency.

Authors:  E Morava; S B Wortmann; H Zweers van Essen; R Liebrand van Sambeek; R Wevers; O P van Diggelen
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Cases in pediatric gastroenterology from The Children's Hospital of Philadelphia: a 2-year-old boy with diarrhea, failure to thrive, and hepatomegaly.

Authors:  Daniel H Leung; Catherine T Chung
Journal:  Medscape J Med       Date:  2009-01-14

Review 3.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

4.  Aggressive therapy improves cirrhosis in glycogen storage disease type IX.

Authors:  Laurie A Tsilianidis; Laurie M Fiske; Sara Siegel; Chris Lumpkin; Kate Hoyt; Melissa Wasserstein; David A Weinstein
Journal:  Mol Genet Metab       Date:  2013-03-21       Impact factor: 4.797

Review 5.  Investigation and management of the hepatic glycogen storage diseases.

Authors:  Kaustuv Bhattacharya
Journal:  Transl Pediatr       Date:  2015-07

6.  A new variant in PHKA2 is associated with glycogen storage disease type IXa.

Authors:  Carmen Rodríguez-Jiménez; Fernando Santos-Simarro; Ángel Campos-Barros; Carmen Camarena; Dolores Lledín; Elena Vallespín; Ángela Del Pozo; Rocío Mena; Pablo Lapunzina; Sonia Rodríguez-Nóvoa
Journal:  Mol Genet Metab Rep       Date:  2017-01-12

7.  Glycogen storage disease presenting as Cushing syndrome.

Authors:  Margaret A Stefater; Joseph I Wolfsdorf; Nina S Ma; Joseph A Majzoub
Journal:  JIMD Rep       Date:  2019-04-03

Review 8.  Mutation in PHKA2 leading to childhood glycogen storage disease type IXa: A case report and literature review.

Authors:  Qian Zhu; Xiao-Yu Wen; Ming-Yuan Zhang; Qing-Long Jin; Jun-Qi Niu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 9.  Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI.

Authors:  Miriam Massese; Francesco Tagliaferri; Carlo Dionisi-Vici; Arianna Maiorana
Journal:  Orphanet J Rare Dis       Date:  2022-06-20       Impact factor: 4.303

10.  Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children.

Authors:  Catarina Leuzinger Dias; Inês Maio; José Ricardo Brandão; Edite Tomás; Esmeralda Martins; Ermelinda Santos Silva
Journal:  GE Port J Gastroenterol       Date:  2019-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.